ß2-integrins as regulators of dendritic cell metabolism and dendritic cell-induced anti-tumor responses

Description of the granted funding

Dendritic cells (DCs) are a type of white blood cells which are of fundamental importance in initiating immune responses, and immunotherapy utilizing these cells, give hope to cure cancer. However, the clinical efficacy of DC vaccines have yet been debatable, and improving the functionality of DCs in patients is clearly required. Integrins are cell surface molecules that play various important roles in the immune system. We are interested in one particular group of integrins which has been shown to negatively regulate DC function. We aim to study the mechanism which is used by these integrins to suppress DC function and then to inhibit this mechanism in order to activate the immune system to fight cancer. We will use mouse DCs and various mouse tumor models to study this. The reseach will take place at the Viikki campus of the University of Helsinki. More information about our research can be found from our website: https://www.helsinki.fi/en/researchgroups/integrins-in-immunity.
Show more

Starting year

2021

End year

2025

Granted funding

Heidi Harjunpää Orcid -palvelun logo
292 429 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

342995

Fields of science

Biochemistry, cell and molecular biology

Research fields

Solu- ja molekyylibiologia

Identified topics

cancer